Correlation Between Anixa Biosciences and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and Ardelyx, you can compare the effects of market volatilities on Anixa Biosciences and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Ardelyx.
Diversification Opportunities for Anixa Biosciences and Ardelyx
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Anixa and Ardelyx is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Ardelyx go up and down completely randomly.
Pair Corralation between Anixa Biosciences and Ardelyx
Given the investment horizon of 90 days Anixa Biosciences is expected to generate 0.89 times more return on investment than Ardelyx. However, Anixa Biosciences is 1.12 times less risky than Ardelyx. It trades about 0.01 of its potential returns per unit of risk. Ardelyx is currently generating about -0.03 per unit of risk. If you would invest 356.00 in Anixa Biosciences on September 1, 2024 and sell it today you would lose (26.00) from holding Anixa Biosciences or give up 7.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anixa Biosciences vs. Ardelyx
Performance |
| Timeline |
| Anixa Biosciences |
| Ardelyx |
Anixa Biosciences and Ardelyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anixa Biosciences and Ardelyx
The main advantage of trading using opposite Anixa Biosciences and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.| Anixa Biosciences vs. Cue Biopharma | Anixa Biosciences vs. INmune Bio | Anixa Biosciences vs. In8bio Inc | Anixa Biosciences vs. PolyPid |
| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |